FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1583392605> ?p ?o ?g. }

• W1583392605 endingPage "49" @default.
• W1583392605 startingPage "37" @default.
• W1583392605 abstract "Flecainide is a Class I antiarrhythmic drug and a potent inhibitor of the cardiac (Nav1.5) sodium channel. Although the flecainide inhibition of Nav1.5 is typically enhanced by depolarization, the contributions of the open and inactivated states to flecainide binding and inhibition remain controversial. We further investigated the state-dependent binding of flecainide by examining its inhibition of rapidly inactivating and non-inactivating mutants of Nav1.5 expressed in Xenopus oocytes. Applying flecainide while briefly depolarizing from a relatively negative holding potential resulted in a low-affinity inhibition of the channel (IC50= 345 μm). Increasing the frequency of stimulation potentiated the flecainide inhibition (IC50= 7.4 μm), which progressively increased over the range of voltages where Nav1.5 channels activated. This contrasts with sustained depolarizations that effectively stabilize the channels in inactivated states, which failed to promote significant flecainide inhibition. The voltage sensitivity and strong dependence of the flecainide inhibition on repetitive depolarization suggests that flecainide binding is facilitated by channel opening and that the drug does not directly bind to closed or inactivated channels. The binding of flecainide to open channels was further investigated in a non-inactivating mutant of Nav1.5. Flecainide produced a time-dependent decay in the current of the non-inactivating mutant that displayed kinetics consistent with a simple pore blocking mechanism (KD= 11 μm). At hyperpolarized voltages, flecainide slowed the recovery of both the rapidly inactivating (τ= 81 ± 3 s) and non-inactivating (τ= 42 ± 3 s) channels. Mutation of a conserved isoleucine of the D4S6 segment (I1756C) creates an alternative pathway that permits the rapid diffusion of anaesthetics out of the Nav1.5 channel. The I1756C mutation accelerated the recovery of both the rapidly inactivating (τ= 12.6 ± 0.4 s) and non-inactivating (τ= 7.4 ± 0.1 s) channels, suggesting that flecainide is trapped and not tightly bound within the pore when the channels are closed or inactivated. The data indicate that flecainide rapidly gains access to its binding site when the channel is open and inhibits Na+ current by a pore blocking mechanism. Closing of either the activation or the inactivation gate traps flecainide within the pore resulting in the slow recovery of the drug-modified channels at hyperpolarized voltages." @default.
• W1583392605 created "2016-06-24" @default.
• W1583392605 creator A5015893104 @default.
• W1583392605 creator A5016356391 @default.
• W1583392605 date "2004-10-01" @default.
• W1583392605 modified "2023-10-17" @default.
• W1583392605 title "State-dependent trapping of flecainide in the cardiac sodium channel" @default.
• W1583392605 cites W1963640428 @default.
• W1583392605 cites W1968903551 @default.
• W1583392605 cites W1972459374 @default.
• W1583392605 cites W1987576284 @default.
• W1583392605 cites W1993584057 @default.
• W1583392605 cites W1996969350 @default.
• W1583392605 cites W2014953544 @default.
• W1583392605 cites W2028982558 @default.
• W1583392605 cites W2032512620 @default.
• W1583392605 cites W2044802282 @default.
• W1583392605 cites W2051199416 @default.
• W1583392605 cites W2057024000 @default.
• W1583392605 cites W2069884282 @default.
• W1583392605 cites W2072732939 @default.
• W1583392605 cites W2075419292 @default.
• W1583392605 cites W2075619581 @default.
• W1583392605 cites W2083714051 @default.
• W1583392605 cites W2085007473 @default.
• W1583392605 cites W2102491071 @default.
• W1583392605 cites W2108132235 @default.
• W1583392605 cites W2115052737 @default.
• W1583392605 cites W2116411564 @default.
• W1583392605 cites W2122544875 @default.
• W1583392605 cites W2126293129 @default.
• W1583392605 cites W2126997063 @default.
• W1583392605 cites W2128567459 @default.
• W1583392605 cites W2144590538 @default.
• W1583392605 cites W2145166035 @default.
• W1583392605 cites W2155932859 @default.
• W1583392605 cites W2156539232 @default.
• W1583392605 cites W2162277138 @default.
• W1583392605 cites W2271846309 @default.
• W1583392605 cites W2409112980 @default.
• W1583392605 cites W2614168425 @default.
• W1583392605 doi "https://doi.org/10.1113/jphysiol.2004.065003" @default.
• W1583392605 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1665201" @default.
• W1583392605 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15272045" @default.
• W1583392605 hasPublicationYear "2004" @default.
• W1583392605 type Work @default.
• W1583392605 sameAs 1583392605 @default.
• W1583392605 citedByCount "84" @default.
• W1583392605 countsByYear W15833926052012 @default.
• W1583392605 countsByYear W15833926052013 @default.
• W1583392605 countsByYear W15833926052014 @default.
• W1583392605 countsByYear W15833926052015 @default.
• W1583392605 countsByYear W15833926052016 @default.
• W1583392605 countsByYear W15833926052017 @default.
• W1583392605 countsByYear W15833926052018 @default.
• W1583392605 countsByYear W15833926052019 @default.
• W1583392605 countsByYear W15833926052020 @default.
• W1583392605 countsByYear W15833926052021 @default.
• W1583392605 countsByYear W15833926052022 @default.
• W1583392605 countsByYear W15833926052023 @default.
• W1583392605 crossrefType "journal-article" @default.
• W1583392605 hasAuthorship W1583392605A5015893104 @default.
• W1583392605 hasAuthorship W1583392605A5016356391 @default.
• W1583392605 hasBestOaLocation W15833926052 @default.
• W1583392605 hasConcept C104317684 @default.
• W1583392605 hasConcept C12554922 @default.
• W1583392605 hasConcept C126322002 @default.
• W1583392605 hasConcept C134018914 @default.
• W1583392605 hasConcept C17077164 @default.
• W1583392605 hasConcept C178790620 @default.
• W1583392605 hasConcept C185592680 @default.
• W1583392605 hasConcept C202751555 @default.
• W1583392605 hasConcept C2776414672 @default.
• W1583392605 hasConcept C2777752497 @default.
• W1583392605 hasConcept C2779161974 @default.
• W1583392605 hasConcept C2779535977 @default.
• W1583392605 hasConcept C2779837460 @default.
• W1583392605 hasConcept C4141045 @default.
• W1583392605 hasConcept C50952357 @default.
• W1583392605 hasConcept C537181965 @default.
• W1583392605 hasConcept C55493867 @default.
• W1583392605 hasConcept C71924100 @default.
• W1583392605 hasConcept C86803240 @default.
• W1583392605 hasConcept C98274493 @default.
• W1583392605 hasConceptScore W1583392605C104317684 @default.
• W1583392605 hasConceptScore W1583392605C12554922 @default.
• W1583392605 hasConceptScore W1583392605C126322002 @default.
• W1583392605 hasConceptScore W1583392605C134018914 @default.
• W1583392605 hasConceptScore W1583392605C17077164 @default.
• W1583392605 hasConceptScore W1583392605C178790620 @default.
• W1583392605 hasConceptScore W1583392605C185592680 @default.
• W1583392605 hasConceptScore W1583392605C202751555 @default.
• W1583392605 hasConceptScore W1583392605C2776414672 @default.
• W1583392605 hasConceptScore W1583392605C2777752497 @default.
• W1583392605 hasConceptScore W1583392605C2779161974 @default.
• W1583392605 hasConceptScore W1583392605C2779535977 @default.
• W1583392605 hasConceptScore W1583392605C2779837460 @default.
• W1583392605 hasConceptScore W1583392605C4141045 @default.

• next